| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1043164968 |
| P356 | DOI | 10.1186/GM322 |
| P932 | PMC publication ID | 3446273 |
| P698 | PubMed publication ID | 22458537 |
| P5875 | ResearchGate publication ID | 223994421 |
| P2093 | author name string | Jane E Hewitt | |
| P2860 | cites work | Dystroglycan function requires xylosyl- and glucuronyltransferase activities of LARGE | Q24301093 |
| Mutant glycosyltransferase and altered glycosylation of alpha-dystroglycan in the myodystrophy mouse | Q28589172 | ||
| O-mannosyl phosphorylation of alpha-dystroglycan is required for laminin binding. | Q34090655 | ||
| Dystroglycan: from biosynthesis to pathogenesis of human disease. | Q36367346 | ||
| Loss of alpha-dystroglycan laminin binding in epithelium-derived cancers is caused by silencing of LARGE. | Q37160880 | ||
| Receptor binding and cell entry of Old World arenaviruses reveal novel aspects of virus-host interaction. | Q37424388 | ||
| Dystroglycanopathies: coming into focus | Q37852376 | ||
| Enhanced laminin binding by alpha-dystroglycan after enzymatic deglycosylation | Q38326990 | ||
| Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies | Q42524150 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 23 | |
| P577 | publication date | 2012-03-29 | |
| P1433 | published in | Genome Medicine | Q15816848 |
| P1476 | title | LARGE enzyme activity deciphered: a new therapeutic target for muscular dystrophies | |
| P478 | volume | 4 |
| Q33930289 | Comparative Analysis of Protein Glycosylation Pathways in Humans and the Fungal Pathogen Candida albicans |
| Q41691404 | Comparative transcriptome analysis of muscular dystrophy models Large(myd), Dmd(mdx)/Large(myd) and Dmd(mdx): what makes them different? |
| Q39314908 | The transgenic expression of LARGE exacerbates the muscle phenotype of dystroglycanopathy mice |
Search more.